JP2019048806A5 - - Google Patents

Download PDF

Info

Publication number
JP2019048806A5
JP2019048806A5 JP2018185491A JP2018185491A JP2019048806A5 JP 2019048806 A5 JP2019048806 A5 JP 2019048806A5 JP 2018185491 A JP2018185491 A JP 2018185491A JP 2018185491 A JP2018185491 A JP 2018185491A JP 2019048806 A5 JP2019048806 A5 JP 2019048806A5
Authority
JP
Japan
Prior art keywords
salt
compound
organic acid
formula
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018185491A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019048806A (ja
JP7098496B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019048806A publication Critical patent/JP2019048806A/ja
Publication of JP2019048806A5 publication Critical patent/JP2019048806A5/ja
Application granted granted Critical
Publication of JP7098496B2 publication Critical patent/JP7098496B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018185491A 2016-12-21 2018-09-28 7H-ピロロ[2,3-d]ピリミジン誘導体の製造方法及びその合成中間体 Active JP7098496B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016247607 2016-12-21
JP2016247607 2016-12-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018518551A Division JP6434678B2 (ja) 2016-12-21 2017-12-20 7H−ピロロ[2,3−d]ピリミジン誘導体の製造方法及びその合成中間体

Publications (3)

Publication Number Publication Date
JP2019048806A JP2019048806A (ja) 2019-03-28
JP2019048806A5 true JP2019048806A5 (enExample) 2021-02-04
JP7098496B2 JP7098496B2 (ja) 2022-07-11

Family

ID=62627423

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018518551A Active JP6434678B2 (ja) 2016-12-21 2017-12-20 7H−ピロロ[2,3−d]ピリミジン誘導体の製造方法及びその合成中間体
JP2018185491A Active JP7098496B2 (ja) 2016-12-21 2018-09-28 7H-ピロロ[2,3-d]ピリミジン誘導体の製造方法及びその合成中間体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018518551A Active JP6434678B2 (ja) 2016-12-21 2017-12-20 7H−ピロロ[2,3−d]ピリミジン誘導体の製造方法及びその合成中間体

Country Status (12)

Country Link
US (3) US11673900B2 (enExample)
EP (1) EP3560932B1 (enExample)
JP (2) JP6434678B2 (enExample)
KR (1) KR102546513B1 (enExample)
CN (2) CN110300756B (enExample)
AU (2) AU2017384317C1 (enExample)
BR (1) BR112019012688A2 (enExample)
CA (1) CA3047891A1 (enExample)
IL (2) IL288080B2 (enExample)
MX (2) MX2019007542A (enExample)
TW (2) TWI854815B (enExample)
WO (1) WO2018117152A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI729990B (zh) 2015-07-07 2021-06-11 日商日本煙草產業股份有限公司 7H-吡咯并[2,3-d]嘧啶衍生物的製造方法及其中間物
TWI854815B (zh) 2016-12-21 2024-09-01 日商日本煙草產業股份有限公司 7H-吡咯并[2,3-d]嘧啶衍生物的製造方法及其合成中間體
CN111574540B (zh) * 2020-06-30 2023-08-29 云南华派医药科技有限公司 一种德高替尼的制备方法
CN111560021B (zh) * 2020-06-30 2023-05-26 上海鲲博玖瑞医药科技发展有限公司 一种德高替尼中间体及其制备方法
CN111606929B (zh) * 2020-06-30 2023-07-07 中瀚(齐河县)生物医药科技有限公司 德高替尼的制备方法
EP4680246A1 (en) 2023-03-17 2026-01-21 LEO Pharma A/S A method for the treatment of chronic hand eczema in patients with moderate to severe chronic hand eczema
WO2024229406A1 (en) 2023-05-04 2024-11-07 Revolution Medicines, Inc. Combination therapy for a ras related disease or disorder
US20250049810A1 (en) 2023-08-07 2025-02-13 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder
TW202530228A (zh) 2023-10-12 2025-08-01 美商銳新醫藥公司 Ras抑制劑
WO2025171296A1 (en) 2024-02-09 2025-08-14 Revolution Medicines, Inc. Ras inhibitors
TW202547461A (zh) 2024-05-17 2025-12-16 美商銳新醫藥公司 Ras抑制劑
WO2025255438A1 (en) 2024-06-07 2025-12-11 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder
WO2025265060A1 (en) 2024-06-21 2025-12-26 Revolution Medicines, Inc. Therapeutic compositions and methods for managing treatment-related effects
WO2026006747A1 (en) 2024-06-28 2026-01-02 Revolution Medicines, Inc. Ras inhibitors
WO2026015801A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015825A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Use of ras inhibitor for treating pancreatic cancer
WO2026015796A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015790A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026050446A1 (en) 2024-08-29 2026-03-05 Revolution Medicines, Inc. Ras inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7662960B2 (en) 2001-04-26 2010-02-16 Choongwae Pharma Corporation Beta-strand mimetics and method relating thereto
WO2004108731A1 (en) * 2003-05-30 2004-12-16 Choongwae Pharma Corporation Beta-strand mimetics and method relating thereto
US7230119B2 (en) 2004-08-25 2007-06-12 Biocryst Pharmaceuticals, Inc. Process for the preparation of substituted pyrrolidine derivatives and intermediates
DK2078022T3 (da) 2006-09-22 2012-02-13 Janssen Pharmaceutica Nv Spirobenzazepiner anvendt som vasopressinantagonister
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
JP2014507414A (ja) 2011-01-19 2014-03-27 ガラパゴス・ナムローゼ・フェンノートシャップ 代謝疾患及び炎症疾患の治療に有用なアゼチジン誘導体
CN103570601B (zh) 2012-07-20 2016-03-30 重庆博腾制药科技股份有限公司 一种光学活性药物中间体的制备方法
HUE034210T2 (hu) 2013-03-05 2018-02-28 Theravance Biopharma R&D Ip Llc Neprilizininhibitorok
JP6500634B2 (ja) * 2015-06-24 2019-04-17 株式会社Ihi 溶接装置及び溶接方法
TWI729990B (zh) * 2015-07-07 2021-06-11 日商日本煙草產業股份有限公司 7H-吡咯并[2,3-d]嘧啶衍生物的製造方法及其中間物
KR102788829B1 (ko) * 2016-12-21 2025-03-31 니뽄 다바코 산교 가부시키가이샤 야누스 키나제 억제제의 결정질 형태
TWI854815B (zh) 2016-12-21 2024-09-01 日商日本煙草產業股份有限公司 7H-吡咯并[2,3-d]嘧啶衍生物的製造方法及其合成中間體

Similar Documents

Publication Publication Date Title
JP2019048806A5 (enExample)
JP2019207442A5 (enExample)
JP2019147825A5 (enExample)
JP2022043078A5 (enExample)
JP2019194236A5 (enExample)
JP2018024670A5 (enExample)
JP2016520672A5 (enExample)
JP2018193405A5 (enExample)
JP2016153424A5 (enExample)
JP2016148024A5 (enExample)
JP2018536572A5 (enExample)
JP2015181191A5 (enExample)
JP2010095546A5 (enExample)
JP2011518833A5 (enExample)
JP2018529687A5 (enExample)
JP2018521020A5 (enExample)
JP2010501516A5 (enExample)
JP2016188255A5 (enExample)
JP2015524822A5 (enExample)
JPWO2021220648A5 (enExample)
JP2009184932A5 (enExample)
JP2007526383A5 (enExample)
JP2010534246A5 (enExample)
JP2013100237A5 (enExample)
JP2018145180A5 (enExample)